Catheter-based therapy for acute ischemic stroke: A national unmet need

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 5, 2008, Pages 705-709

  DeVries, James T ^a   White, Christopher J ^a   Cunningham, Michael C ^a   Ramee, Steven R ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Embolization; Peripheral vascular disease; Thrombosis

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; ATAXIC APHASIA; BRAIN ANGIOGRAPHY; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DYSARTHRIA; FEMALE; FIBRINOLYTIC THERAPY; HEMIPLEGIA; HUMAN; MALE; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY OCCLUSION; PERCUTANEOUS THROMBECTOMY; VASCULAR PATENCY; BRAIN CIRCULATION; BRAIN EMBOLISM; CATHETERIZATION; CEREBRAL ARTERY DISEASE; EMBOLECTOMY; EQUIPMENT DESIGN; INSTRUMENTATION; MIDDLE AGED; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PATIENT CARE; RADIOGRAPHY; REPERFUSION; THROMBECTOMY; TREATMENT OUTCOME;

AGED; CATHETERIZATION; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; EMBOLECTOMY; EQUIPMENT DESIGN; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL EMBOLISM; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PATIENT CARE TEAM; REPERFUSION; THROMBECTOMY; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 58749093612     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21633     Document Type: Article

References (17)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Mov C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
2. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997;28:1507-1517.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
4. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US Estimates of Recombinant Tissue Plasminogen Activator Use. ICD-9 Codes Substantially Underestimate. Stroke 2008;39:924-928.
5. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999;282:2019-2026.
6. Suzuki S, Saver JL, Scott P, Jahan R, Duckwiler G, Starkman S, Su Y, Kidwell CS. Access to intra-arterial therapies for acute ischemic stroke: An analysis of the US population. AJNR Am J Neuroradiol 2004;25:1802-1806.
7. Ramee SR, Subramanian R, Felberg RA, McKinley KL, Jenkins JS, Collins TJ, Dawson RC, White CJ. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004;35:e109-e111.
8. NIHSS Web Page. Volume 2008.
9. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006;37:2086-2093.
10. Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, Alwell K, Gebel J, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Shukla R, Broderick JP. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study. Stroke 2004;35:e27-e29.
11. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999;340:1781-1787.
12. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, Seo SH, Kim DI, Heo JH. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 2007;38:192-193.
13. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3-13.
14. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
15. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP;MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005;36: 1432-1438.
16. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605.
17. White CJ, Cates CU, Cowley MJ, Weiner BH, Carpenter JS, Hopkins LN, Jaff MR, Ramee SR, Rymer MM, Wholey MH. Interventional stroke therapy: Current state of the art and needs assessment. Cathet Cardiovasc Interv 2007;70:471-476.